"FDA"^^ . "OPRELVEKINPTFDAHM5641GA6F" . . . "Recombinant Human Interleukin-11SYNCI" . "A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin 11 (IL-11). Secreted by bone marrow stromal cells and a number of mesenchymal cells, IL-11 binds to and activates its cell-surface receptor, promoting primary and secondary immune responses, modulating antigen-specific antibody reactions, and preventing apoptotic cell death. This agent also stimulates the T-cell-dependent development of IgG-secreting B-cells in spleen cell cultures and may be an important regulator of megakaryocytopoiesis. (NCI04)NCI" . "Pharmacologic Substance"^^ . "Adipogenesis Inhibitory FactorSYNCI" . "145941-26-0"^^ . . "recombinant human interleukin-11PTNCI-GLOSSCDR0000580268" . "Chemotherapy-related thrombocytopenia"^^ . "OprelvekinPTNCI" . "A drug used to increase the number of blood cells, especially platelets, in some cancer patients receiving chemotherapy. Neumega is a form of interleukin-11 (a cytokine normally made by support cells in the bone marrow) that is made in the laboratory. It is a type of biological response modifier.NCI-GLOSS" . "Amino Acid, Peptide, or Protein"^^ . "42365"^^ . "Therapeutic_Interleukin-11"^^ . "rhIL-11PTNCI-GLOSSCDR0000580275" . "42365"^^ . "Interleukin-11-RecombinantSYNCI" . "HM5641GA6F"^^ . . . "rhIL-11ABNCI" . "Recombinant Interleukin-11SYNCI" . "oprelvekinPTNCI-GLOSSCDR0000520411" . "Oprelvekin"^^ . "Immunologic Factor"^^ . "Oprelvekin"^^ . "C1303"^^ . "C0537670"^^ . "IL-11ABNCI" . "Interleukin 11SYNCI" . "NeumegaBRNCI" . "Non-Hodgkins lymphoma; Crohns disease"^^ . "NeumegaPTNCI-GLOSSCDR0000580234" . "Interleukin-11SYNCI" .